Vista Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

5.45

-

0.11

0.29

0.41

Operating profit

-2.09

-0.35

-0.47

-0.74

-0.68

Interest

0.64

0.49

0.55

0.35

0.98

Gross profit

-2.52

-0.84

-0.78

-1.16

-1.58

EPS (Rs)

-0.67

-0.23

0.40

-0.63

-0.30

Other income

0.21

-

0.24

-0.08

0.08

Stock adjustment

-

-

-0.26

0.26

-

Raw material

5.18

-

0.35

0.01

0.37

Power and fuel

-

-

-

-

-

Employee expenses

0.86

0.08

0.18

0.39

0.38

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1.50

0.27

0.31

0.36

0.34

Provisions made

-

-

-

-

-

Depreciation

0.36

0.31

0.31

0.31

0.36

Taxation

0.10

-0.32

-2.56

0.84

-0.83

Net profit / loss

-2.97

-0.83

1.48

-2.31

-1.10

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

8.84

7.36

7.36

7.36

7.36

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-38.32

-

-431.68

-258.97

-167.22

GPM (%)

-44.54

-

-223.25

-554.71

-320.15

NPM (%)

-52.52

-

420.28

-1102.25

-223.61